Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Animal Drug Compounding Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Anti-Infective Agents
  • 1.3.3 Hormones and Substitutes
  • 1.3.4 Anti-Inflammatory Agents
  • 1.3.5 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Animal Drug Compounding Market Share by Application (2019-2025)
  • 1.4.2 Veterinary Hospitals
  • 1.4.3 Veterinary Clinics
  • 1.4.4 Veterinary Diagnostic Centers
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Animal Drug Compounding Market Size
  • 2.1.1 Global Animal Drug Compounding Revenue 2014-2025
  • 2.1.2 Global Animal Drug Compounding Sales 2014-2025
• 2.2 Animal Drug Compounding Growth Rate by Regions
  • 2.2.1 Global Animal Drug Compounding Sales by Regions 2014-2019
  • 2.2.2 Global Animal Drug Compounding Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Animal Drug Compounding Sales by Manufacturers
  • 3.1.1 Animal Drug Compounding Sales by Manufacturers 2014-2019
  • 3.1.2 Animal Drug Compounding Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Animal Drug Compounding Revenue by Manufacturers (2014-2019)
  • 3.2.2 Animal Drug Compounding Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Animal Drug Compounding Market Concentration Ratio (CR5 and HHI)
• 3.3 Animal Drug Compounding Price by Manufacturers
• 3.4 Key Manufacturers Animal Drug Compounding Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Animal Drug Compounding Market
• 3.6 Key Manufacturers Animal Drug Compounding Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Anti-Infective Agents Sales and Revenue (2014-2019)
  • 4.1.2 Hormones and Substitutes Sales and Revenue (2014-2019)
  • 4.1.3 Anti-Inflammatory Agents Sales and Revenue (2014-2019)
  • 4.1.4 Others Sales and Revenue (2014-2019)
• 4.2 Global Animal Drug Compounding Sales Market Share by Type
• 4.3 Global Animal Drug Compounding Revenue Market Share by Type
• 4.4 Animal Drug Compounding Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Animal Drug Compounding Sales by Application

6 United States

• 6.1 United States Animal Drug Compounding Breakdown Data by Company
• 6.2 United States Animal Drug Compounding Breakdown Data by Type
• 6.3 United States Animal Drug Compounding Breakdown Data by Application

7 European Union

• 7.1 European Union Animal Drug Compounding Breakdown Data by Company
• 7.2 European Union Animal Drug Compounding Breakdown Data by Type
• 7.3 European Union Animal Drug Compounding Breakdown Data by Application

8 China

• 8.1 China Animal Drug Compounding Breakdown Data by Company
• 8.2 China Animal Drug Compounding Breakdown Data by Type
• 8.3 China Animal Drug Compounding Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Animal Drug Compounding Breakdown Data by Company
• 9.2 Rest of World Animal Drug Compounding Breakdown Data by Type
• 9.3 Rest of World Animal Drug Compounding Breakdown Data by Application
• 9.4 Rest of World Animal Drug Compounding Breakdown Data by Countries
  • 9.4.1 Rest of World Animal Drug Compounding Sales by Countries
  • 9.4.2 Rest of World Animal Drug Compounding Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Triangle Compounding Pharmacy
  • 10.1.1 Triangle Compounding Pharmacy Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Animal Drug Compounding
  • 10.1.4 Animal Drug Compounding Product Introduction
  • 10.1.5 Triangle Compounding Pharmacy Recent Development
• 10.2 Lorraine's Pharmacy
  • 10.2.1 Lorraine's Pharmacy Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Animal Drug Compounding
  • 10.2.4 Animal Drug Compounding Product Introduction
  • 10.2.5 Lorraine's Pharmacy Recent Development
• 10.3 Medisca
  • 10.3.1 Medisca Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Animal Drug Compounding
  • 10.3.4 Animal Drug Compounding Product Introduction
  • 10.3.5 Medisca Recent Development
• 10.4 Diamondback Drugs
  • 10.4.1 Diamondback Drugs Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Animal Drug Compounding
  • 10.4.4 Animal Drug Compounding Product Introduction
  • 10.4.5 Diamondback Drugs Recent Development
• 10.5 ESSENTIAL PHARMACY COMPOUNDING VET
  • 10.5.1 ESSENTIAL PHARMACY COMPOUNDING VET Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Animal Drug Compounding
  • 10.5.4 Animal Drug Compounding Product Introduction
  • 10.5.5 ESSENTIAL PHARMACY COMPOUNDING VET Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Animal Drug Compounding Sales Channels
  • 11.2.2 Animal Drug Compounding Distributors
• 11.3 Animal Drug Compounding Customers

12 Market Forecast

• 12.1 Global Animal Drug Compounding Sales and Revenue Forecast 2019-2025
• 12.2 Global Animal Drug Compounding Sales Forecast by Type
• 12.3 Global Animal Drug Compounding Sales Forecast by Application
• 12.4 Animal Drug Compounding Forecast by Regions
  • 12.4.1 Global Animal Drug Compounding Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Animal Drug Compounding Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as “customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient.
Animal drug shortages are becoming more common and this is unfortunately predicted to worsen in the years ahead, as per official reports published by veterinarians. This shortage encourages the use of widely available compounded drugs to treat a number of animal diseases. A few critical animal drug shortages highlighted by the U.S. FDA are Flunixine Injectable, 35% Perox-Aid, and Epinephrine. To make medical therapy suitable for animal requirements, compounded drugs with the desired active ingredients are unavailable. For e.g., no FDA approved drug for treating megacolon in cats is currently available in the animal drug compounding market. The only safe and effective therapy to treat chronic cat constipation was removed from the U.S. nearly two decades ago. That is why compounding drugs are the only option for veterinarians to treat animals that need pro-kinetic drug therapy.
In 2019, the market size of Animal Drug Compounding is 840 million US$ and it will reach 1370 million US$ in 2025, growing at a CAGR of 6.2% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Animal Drug Compounding.

This report studies the global market size of Animal Drug Compounding, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Animal Drug Compounding sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Triangle Compounding Pharmacy
Lorraine's Pharmacy
Medisca
Diamondback Drugs
ESSENTIAL PHARMACY COMPOUNDING VET
...

Market Segment by Product Type
Anti-Infective Agents
Hormones and Substitutes
Anti-Inflammatory Agents
Others

Market Segment by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Diagnostic Centers

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Animal Drug Compounding status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Animal Drug Compounding manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Animal Drug Compounding are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025